Wedbush Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Wedbush
Rating: 2.7
Author: MarketBeat

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Wedbush. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Wedbush.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
ORLY O'Reilly Automotive	$1,020.83 -4.3%	2/8/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$940.00 -> $1,100.00	Low	View details for Wedbush rating of O’Reilly Automotive (NASDAQ:ORLY) on 2/8/2024
SIMO Silicon Motion Technology	$67.90 +1.4%	2/8/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$85.00	Low	View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 2/8/2024
RBLX Roblox	$44.86 +0.3%	2/8/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$53.00 -> $56.00	Low	View details for Wedbush rating of Roblox (NYSE:RBLX) on 2/8/2024
QLYS Qualys	$169.65 -4.2%	2/8/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$230.00 -> $210.00	Low	View details for Wedbush rating of Qualys (NASDAQ:QLYS) on 2/8/2024
PYPL PayPal	$56.13 -11.2%	2/8/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$85.00	Low	View details for Wedbush rating of PayPal (NASDAQ:PYPL) on 2/8/2024
ASND Ascendis Pharma A/S	$139.25 0.0%	2/8/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$207.00 -> $225.00	Low	View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 2/8/2024
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
PCRX Pacira BioSciences	$27.70 -2.8%	2/8/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$57.00	Low	View details for Wedbush rating of Pacira BioSciences (NASDAQ:PCRX) on 2/8/2024
GPRO GoPro	$2.58 -11.0%	2/8/2024	Downgraded by	Wedbush	-	Outperform -> Neutral	$4.00 -> $2.00	Low	View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 2/8/2024
CMG Chipotle Mexican Grill	$2,620.48 -1.7%	2/7/2024	Reiterated by	Wedbush	Analyst N. Setyan	Neutral -> Neutral	$2,400.00	Low	View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 2/7/2024
TXRH Texas Roadhouse	$135.49 +2.2%	2/7/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$130.00 -> $145.00	Low	View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 2/7/2024
WEN Wendy's	$19.08 +0.8%	2/7/2024	Target Lowered by	Wedbush	Analyst N. Setyan	Neutral -> Neutral	$21.00 -> $20.00	Low	View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 2/7/2024
CRSR Corsair Gaming	$12.99 +1.4%	2/7/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$21.00	Low	View details for Wedbush rating of Corsair Gaming (NASDAQ:CRSR) on 2/7/2024
SHOO Steven Madden	$40.96 +1.8%	2/7/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$36.00 -> $38.00	Low	View details for Wedbush rating of Steven Madden (NASDAQ:SHOO) on 2/7/2024
RLYB Rallybio	$1.71 +1.2%	2/7/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$14.00 -> $13.00	Low	View details for Wedbush rating of Rallybio (NASDAQ:RLYB) on 2/7/2024
VFC V.F.	$15.35 +0.3%	2/7/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$16.50 -> $15.50	Low	View details for Wedbush rating of V.F. (NYSE:VFC) on 2/7/2024
CRNC Cerence	$15.80 -1.0%	2/7/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$19.00 -> $21.00	N/A	View details for Wedbush rating of Cerence (NASDAQ:CRNC) on 2/7/2024
CHKP Check Point Software Technologies	$163.18 -0.7%	2/7/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$170.00 -> $185.00	Low	View details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 2/7/2024
TENB Tenable	$50.72 +1.1%	2/7/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$50.00 -> $65.00	Low	View details for Wedbush rating of Tenable (NASDAQ:TENB) on 2/7/2024
FTNT Fortinet	$67.85 -3.1%	2/7/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$75.00 -> $86.00	Low	View details for Wedbush rating of Fortinet (NASDAQ:FTNT) on 2/7/2024
SKY Skyline Champion	$79.51 +2.6%	2/6/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Neutral -> Neutral	$72.00	Low	View details for Wedbush rating of Skyline Champion (NYSE:SKY) on 2/6/2024
LGIH LGI Homes	$118.96 +2.1%	2/6/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$97.00	Low	View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 2/6/2024
RANI Rani Therapeutics	$3.80	2/6/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$8.00	Low	View details for Wedbush rating of Rani Therapeutics (NASDAQ:RANI) on 2/6/2024
PLTR Palantir Technologies	$24.51 +3.9%	2/6/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$25.00 -> $30.00	Low	View details for Wedbush rating of Palantir Technologies (NYSE:PLTR) on 2/6/2024
VRNS Varonis Systems	$50.69 +4.6%	2/6/2024	Upgraded by	Wedbush	Analyst D. Ives	Neutral -> Outperform	$35.00 -> $65.00	Low	View details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 2/6/2024
MCD McDonald's	$291.93 +1.6%	2/6/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$330.00	Low	View details for Wedbush rating of McDonald’s (NYSE:MCD) on 2/6/2024
ACET Adicet Bio	$3.38 +5.3%	2/5/2024	Reiterated by	Wedbush	-	Outperform	$15.00	Low	View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 2/5/2024
BPMC Blueprint Medicines	$74.16 -0.1%	2/5/2024	Reiterated by	Wedbush	-	Outperform	$97.00	Low	View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 2/5/2024
GPRO GoPro	$2.58 -11.0%	2/2/2024	Reiterated by	Wedbush	-	Outperform	$5.00 -> $4.00	Low	View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 2/2/2024
META Meta Platforms	$470.00 +0.1%	2/2/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$420.00 -> $520.00	Low	View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 2/2/2024
DECK Deckers Outdoor	$832.41 -0.1%	2/2/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$825.00 -> $895.00	Low	View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 2/2/2024
BZH Beazer Homes USA	$29.44 +2.9%	2/2/2024	Target Raised by	Wedbush	Analyst J. Mccanless	Neutral -> Neutral	$32.00 -> $33.00	Low	View details for Wedbush rating of Beazer Homes USA (NYSE:BZH) on 2/2/2024
SKX Skechers U.S.A.	$57.98 +1.6%	2/2/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$75.00 -> $68.00	Low	View details for Wedbush rating of Skechers U.S.A. (NYSE:SKX) on 2/2/2024
TSCO Tractor Supply	$231.83 -0.7%	2/2/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$200.00 -> $235.00	Low	View details for Wedbush rating of Tractor Supply (NASDAQ:TSCO) on 2/2/2024
AMZN Amazon.com	$169.84 -0.4%	2/2/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$210.00 -> $220.00	Low	View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 2/2/2024
MTH Meritage Homes	$154.54 +0.7%	2/1/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Neutral -> Neutral	$170.00	Low	View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 2/1/2024
TCRX TScan Therapeutics	$6.00 +3.4%	2/1/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$9.00	Low	View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 2/1/2024
NYCB New York Community Bancorp	$4.19 -6.7%	2/1/2024	Reiterated by	Wedbush	Analyst D. Chiaverini	Underperform -> Underperform	$6.00	Low	View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 2/1/2024
CCS Century Communities	$87.44 +1.9%	2/1/2024	Target Raised by	Wedbush	Analyst J. Mccanless	Neutral -> Neutral	$81.00 -> $92.00	Low	View details for Wedbush rating of Century Communities (NYSE:CCS) on 2/1/2024
RBLX Roblox	$44.86 +0.3%	1/31/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$53.00	Low	View details for Wedbush rating of Roblox (NYSE:RBLX) on 1/31/2024
PHM PulteGroup	$103.26 +0.2%	1/31/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$85.00	Low	View details for Wedbush rating of PulteGroup (NYSE:PHM) on 1/31/2024

ARE Alexandria Real Estate Equities	$117.90 +0.6%	1/31/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$140.00	Low	View details for Wedbush rating of Alexandria Real Estate Equities (NYSE:ARE) on 1/31/2024
LC LendingClub	$8.59 +1.2%	1/31/2024	Reiterated by	Wedbush	Analyst D. Chiaverini	Outperform -> Outperform	$11.00	Low	View details for Wedbush rating of LendingClub (NYSE:LC) on 1/31/2024
AX Axos Financial	$50.31 -0.4%	1/31/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$59.00 -> $62.00	Low	View details for Wedbush rating of Axos Financial (NYSE:AX) on 1/31/2024
HOPE Hope Bancorp	$10.61 +1.1%	1/31/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$13.00 -> $12.00	Low	View details for Wedbush rating of Hope Bancorp (NASDAQ:HOPE) on 1/31/2024
GOOGL Alphabet	$145.91 +0.3%	1/31/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$160.00	Low	View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 1/31/2024
VFC V.F.	$15.35 +0.3%	1/31/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$15.00 -> $16.50	Low	View details for Wedbush rating of V.F. (NYSE:VFC) on 1/31/2024
AMD Advanced Micro Devices	$169.35 -0.9%	1/31/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$200.00	Low	View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 1/31/2024
TSLA Tesla	$189.56 +1.1%	1/31/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$315.00	Low	View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 1/31/2024
GM General Motors	$38.65 -0.2%	1/31/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$40.00 -> $45.00	Low	View details for Wedbush rating of General Motors (NYSE:GM) on 1/31/2024
EA Electronic Arts	$138.85 +1.5%	1/31/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$162.00	Low	View details for Wedbush rating of Electronic Arts (NASDAQ:EA) on 1/31/2024
SBUX Starbucks	$96.59 +1.9%	1/31/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$95.00	Low	View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 1/31/2024
BKNG Booking	$3,840.22 +3.5%	1/30/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$3,850.00	Low	View details for Wedbush rating of Booking (NASDAQ:BKNG) on 1/30/2024
ABNB Airbnb	$150.54 +2.0%	1/30/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$135.00 -> $150.00	Low	View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 1/30/2024
HMST HomeStreet	$12.53	1/30/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$15.00 -> $16.00	Low	View details for Wedbush rating of HomeStreet (NASDAQ:HMST) on 1/30/2024
PPBI Pacific Premier Bancorp	$24.06 +0.7%	1/30/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$31.00 -> $30.00	Low	View details for Wedbush rating of Pacific Premier Bancorp (NASDAQ:PPBI) on 1/30/2024
RCUS Arcus Biosciences	$15.21 +2.6%	1/30/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$36.00 -> $30.00	Low	View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 1/30/2024
INZY Inozyme Pharma	$5.45 +2.1%	1/30/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$15.00	Low	View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 1/30/2024
PEPG PepGen	$15.09 +20.6%	1/30/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$21.00	Low	View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 1/30/2024
ATXS Astria Therapeutics	$15.26 +3.2%	1/30/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$17.00	Low	View details for Wedbush rating of Astria Therapeutics (NASDAQ:ATXS) on 1/30/2024
SMCI Super Micro Computer	$698.00 +2.1%	1/30/2024	Target Raised by	Wedbush	Analyst M. Bryson	Neutral -> Neutral	$250.00 -> $530.00	Low	View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 1/30/2024
AAPL Apple	$188.32 -0.6%	1/30/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$250.00	Low	View details for Wedbush rating of Apple (NASDAQ:AAPL) on 1/30/2024
SQ Block	$68.81 +0.7%	1/30/2024	Upgraded by	Wedbush	Analyst M. Katri	Neutral -> Outperform	$70.00 -> $90.00	Low	View details for Wedbush rating of Block (NYSE:SQ) on 1/30/2024
SRPT Sarepta Therapeutics	$127.38 +1.1%	1/29/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$224.00	Low	View details for Wedbush rating of Sarepta Therapeutics (NASDAQ:SRPT) on 1/29/2024
FCNCA First Citizens BancShares	$1,478.12 -0.4%	1/29/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$1,800.00	Low	View details for Wedbush rating of First Citizens BancShares (NASDAQ:FCNCA) on 1/29/2024
MSFT Microsoft	$414.11 +0.0%	1/29/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$450.00	Low	View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 1/29/2024
CELH Celsius	$58.71 +1.6%	1/29/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$75.00	Low	View details for Wedbush rating of Celsius (NASDAQ:CELH) on 1/29/2024
BKU BankUnited	$26.01 +4.5%	1/29/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$34.00 -> $31.00	Low	View details for Wedbush rating of BankUnited (NYSE:BKU) on 1/29/2024
V Visa	$275.80 -1.1%	1/26/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$270.00 -> $280.00	Low	View details for Wedbush rating of Visa (NYSE:V) on 1/26/2024
INTC Intel	$42.50 -0.7%	1/26/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$45.00 -> $40.00	Low	View details for Wedbush rating of Intel (NASDAQ:INTC) on 1/26/2024
JACK Jack in the Box	$77.08 +1.4%	1/26/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$83.00	Low	View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 1/26/2024
CUBI Customers Bancorp	$50.30 -0.4%	1/26/2024	Target Lowered by	Wedbush	-	Outperform -> Outperform	$70.00 -> $65.00	Low	View details for Wedbush rating of Customers Bancorp (NYSE:CUBI) on 1/26/2024
CFR Cullen/Frost Bankers	$101.76 +0.5%	1/26/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$115.00	Low	View details for Wedbush rating of Cullen/Frost Bankers (NYSE:CFR) on 1/26/2024
FFWM First Foundation	$8.19 +3.3%	1/26/2024	Target Raised by	Wedbush	Analyst D. Chiaverini	Neutral -> Neutral	$10.00 -> $11.00	Low	View details for Wedbush rating of First Foundation (NASDAQ:FFWM) on 1/26/2024
ALPN Alpine Immune Sciences	$28.41 +4.8%	1/26/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$26.00 -> $35.00	Low	View details for Wedbush rating of Alpine Immune Sciences (NASDAQ:ALPN) on 1/26/2024
FUSN Fusion Pharmaceuticals	$11.32 -4.3%	1/26/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$13.00	Low	View details for Wedbush rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 1/26/2024
VERA Vera Therapeutics	$37.56 +0.1%	1/26/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$16.00 -> $21.00	Low	View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 1/26/2024
DNTH Dianthus Therapeutics	$23.20 -4.1%	1/26/2024	Target Raised by	Wedbush	Analyst L. Chico	Outperform -> Outperform	$23.00 -> $24.00	Low	View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 1/26/2024
BANC Banc of California	$12.96 +1.7%	1/26/2024	Target Raised by	Wedbush	Analyst D. Chiaverini	Neutral -> Neutral	$14.00 -> $16.00	Low	View details for Wedbush rating of Banc of California (NYSE:BANC) on 1/26/2024
VLY Valley National Bancorp	$8.25 +3.3%	1/26/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$12.00 -> $11.00	Low	View details for Wedbush rating of Valley National Bancorp (NASDAQ:VLY) on 1/26/2024
STX Seagate Technology	$87.68 +1.1%	1/25/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$100.00	Low	View details for Wedbush rating of Seagate Technology (NASDAQ:STX) on 1/25/2024
DECK Deckers Outdoor	$832.41 -0.1%	1/25/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$705.00 -> $825.00	Low	View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 1/25/2024
CVBF CVB Financial	$17.11 -0.2%	1/25/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$22.00 -> $21.00	Low	View details for Wedbush rating of CVB Financial (NASDAQ:CVBF) on 1/25/2024
COLB Columbia Banking System	$18.78 +2.2%	1/25/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$29.00 -> $24.00	Low	View details for Wedbush rating of Columbia Banking System (NASDAQ:COLB) on 1/25/2024
LRN Stride	$60.10 +2.6%	1/24/2024	Reiterated by	Wedbush	-	Outperform		Low	View details for Wedbush rating of Stride (NYSE:LRN) on 1/24/2024
NFLX Netflix	$558.53 -0.1%	1/24/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$525.00 -> $615.00	Low	View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 1/24/2024
HAFC Hanmi Financial	$14.86 +0.1%	1/24/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$21.00 -> $20.00	Low	View details for Wedbush rating of Hanmi Financial (NASDAQ:HAFC) on 1/24/2024
EWBC East West Bancorp	$69.17 0.0%	1/24/2024	Reiterated by	Wedbush	Analyst D. Chiaverini	Outperform -> Outperform	$86.00	Low	View details for Wedbush rating of East West Bancorp (NASDAQ:EWBC) on 1/24/2024
PRPL Purple Innovation	$1.29 +11.2%	1/24/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$1.25	Low	View details for Wedbush rating of Purple Innovation (NASDAQ:PRPL) on 1/24/2024
BBY Best Buy	$75.49 +0.0%	1/24/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$70.00 -> $75.00	Low	View details for Wedbush rating of Best Buy (NYSE:BBY) on 1/24/2024
LOGI Logitech International	$84.60 +1.5%	1/24/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$90.00 -> $92.00	Low	View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 1/24/2024

SRRK Scholar Rock	$15.71 -1.9%	1/23/2024	Reiterated by	Wedbush	-	Outperform	$23.00	Low	View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 1/23/2024
DHI D.R. Horton	$144.58 0.0%	1/23/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$115.00	Low	View details for Wedbush rating of D.R. Horton (NYSE:DHI) on 1/23/2024
IMNM Immunome	$23.49 -5.7%	1/23/2024	Target Raised by	Wedbush	Analyst D. Nierengarten	Outperform -> Outperform	$12.00 -> $19.00	Low	View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 1/23/2024
ZION Zions Bancorporation, National Association	$39.89 +1.8%	1/23/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$48.00 -> $46.00	Low	View details for Wedbush rating of Zions Bancorporation, National Association (NASDAQ:ZION) on 1/23/2024
TSLA Tesla	$189.56 +1.1%	1/23/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$350.00	Low	View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 1/23/2024
KEY KeyCorp	$13.87 -0.2%	1/19/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$16.00 -> $14.00	Low	View details for Wedbush rating of KeyCorp (NYSE:KEY) on 1/19/2024
TCBI Texas Capital Bancshares	$59.37 +0.7%	1/19/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$70.00 -> $68.00	Low	View details for Wedbush rating of Texas Capital Bancshares (NASDAQ:TCBI) on 1/19/2024
IKNA Ikena Oncology	$1.40	1/19/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$8.00	Low	View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 1/19/2024
AMZN Amazon.com	$169.84 -0.4%	1/19/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$210.00	Low	View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 1/19/2024
SMCI Super Micro Computer	$698.00 +2.1%	1/19/2024	Reiterated by	Wedbush	Analyst M. Bryson	Neutral -> Neutral	$250.00	Low	View details for Wedbush rating of Super Micro Computer (NASDAQ:SMCI) on 1/19/2024
JACK Jack in the Box	$77.08 +1.4%	1/19/2024	Reiterated by	Wedbush	-	Neutral -> Neutral	$83.00	Low	View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 1/19/2024
VOR Vor Biopharma	$2.30 +0.4%	1/18/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$11.00	Low	View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 1/18/2024
WTFC Wintrust Financial	$92.61 +1.3%	1/18/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$110.00	Low	View details for Wedbush rating of Wintrust Financial (NASDAQ:WTFC) on 1/18/2024
LOGI Logitech International	$84.60 +1.5%	1/18/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$90.00 -> $92.00	Low	View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 1/18/2024
CFG Citizens Financial Group	$31.37 +0.2%	1/18/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$36.00 -> $35.00	Low	View details for Wedbush rating of Citizens Financial Group (NYSE:CFG) on 1/18/2024
SBUX Starbucks	$96.59 +1.9%	1/18/2024	Target Lowered by	Wedbush	-	Neutral -> Neutral	$100.00 -> $95.00	Low	View details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 1/18/2024
RGNX REGENXBIO	$16.29 +11.8%	1/17/2024	Reiterated by	Wedbush	-	Neutral	$21.00	Low	View details for Wedbush rating of REGENXBIO (NASDAQ:RGNX) on 1/17/2024
SKX Skechers U.S.A.	$57.98 +1.6%	1/17/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$62.00 -> $75.00	Low	View details for Wedbush rating of Skechers U.S.A. (NYSE:SKX) on 1/17/2024
RCUS Arcus Biosciences	$15.21 +2.6%	1/17/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$36.00	Low	View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 1/17/2024
KNTE Kinnate Biopharma	$2.31 -2.1%	1/17/2024	Reiterated by	Wedbush	Analyst D. Nierengarten	Neutral -> Neutral	$2.00	Low	View details for Wedbush rating of Kinnate Biopharma (NASDAQ:KNTE) on 1/17/2024
KMX CarMax	$73.30 +1.4%	1/17/2024	Reiterated by	Wedbush	Analyst S. Basham	Outperform -> Outperform	$90.00	Low	View details for Wedbush rating of CarMax (NYSE:KMX) on 1/17/2024
XOS XOS	$7.90 -0.8%	1/16/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$13.00	Low	View details for Wedbush rating of XOS (NASDAQ:XOS) on 1/16/2024
INFY Infosys	$20.20 -1.1%	1/16/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$22.00	Low	View details for Wedbush rating of Infosys (NYSE:INFY) on 1/16/2024
WIT Wipro	$5.85 -1.0%	1/16/2024	Target Raised by	Wedbush	-	Underperform -> Underperform	$4.00 -> $6.00	Low	View details for Wedbush rating of Wipro (NYSE:WIT) on 1/16/2024
TSLA Tesla	$189.56 +1.1%	1/16/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$350.00	Low	View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 1/16/2024
ARDX Ardelyx	$9.27 +3.3%	1/12/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$9.00 -> $13.00	Low	View details for Wedbush rating of Ardelyx (NASDAQ:ARDX) on 1/12/2024
PRAX Praxis Precision Medicines	$45.04 +2.1%	1/12/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$16.00 -> $29.00	Low	View details for Wedbush rating of Praxis Precision Medicines (NASDAQ:PRAX) on 1/12/2024
APLS Apellis Pharmaceuticals	$68.12 +2.1%	1/12/2024	Target Raised by	Wedbush	-	Neutral -> Neutral	$39.00 -> $60.00	Low	View details for Wedbush rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 1/12/2024
KBH KB Home	$60.66 +1.2%	1/11/2024	Target Raised by	Wedbush	Analyst J. Mccanless	Neutral -> Neutral	$55.00 -> $60.00	Low	View details for Wedbush rating of KB Home (NYSE:KBH) on 1/11/2024
COIN Coinbase Global	$132.55 +8.6%	1/11/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$110.00 -> $180.00	Low	View details for Wedbush rating of Coinbase Global (NASDAQ:COIN) on 1/11/2024
PZZA Papa John's International	$73.66 0.0%	1/11/2024	Reiterated by	Wedbush	Analyst N. Setyan	Outperform -> Outperform	$85.00 -> $87.00	Low	View details for Wedbush rating of Papa John’s International (NASDAQ:PZZA) on 1/11/2024
WSM Williams-Sonoma	$215.79 +5.0%	1/11/2024	Upgraded by	Wedbush	Analyst S. Basham	Neutral -> Outperform	$175.00 -> $230.00	Low	View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 1/11/2024
GPN Global Payments	$136.53 -0.4%	1/10/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$130.00 -> $160.00	Low	View details for Wedbush rating of Global Payments (NYSE:GPN) on 1/10/2024
HD Home Depot	$363.84 +0.3%	1/10/2024	Upgraded by	Wedbush	Analyst S. Basham	Neutral -> Outperform	$330.00 -> $380.00	Low	View details for Wedbush rating of Home Depot (NYSE:HD) on 1/10/2024
LSEA Landsea Homes	$12.08 +3.3%	1/9/2024	Reiterated by	Wedbush	-	Outperform	$16.00	Low	View details for Wedbush rating of Landsea Homes (NASDAQ:LSEA) on 1/9/2024
COGT Cogent Biosciences	$6.38 +7.2%	1/9/2024	Reiterated by	Wedbush	Analyst D. Nierengarten	Neutral		Low	View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 1/9/2024
GEO The GEO Group	$12.02 +5.0%	1/9/2024	Reiterated by	Wedbush	-	Outperform	$14.00	Low	View details for Wedbush rating of The GEO Group (NYSE:GEO) on 1/9/2024
SRPT Sarepta Therapeutics	$127.38 +1.1%	1/9/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$224.00	Low	View details for Wedbush rating of Sarepta Therapeutics (NASDAQ:SRPT) on 1/9/2024
BLUE bluebird bio	$1.05 +11.7%	1/8/2024	Reiterated by	Wedbush	-	Neutral	$3.00	Low	View details for Wedbush rating of bluebird bio (NASDAQ:BLUE) on 1/8/2024
BPMC Blueprint Medicines	$74.16 -0.1%	1/8/2024	Reiterated by	Wedbush	-	Outperform	$100.00 -> $97.00	Low	View details for Wedbush rating of Blueprint Medicines (NASDAQ:BPMC) on 1/8/2024
IMNM Immunome	$23.49 -5.7%	1/8/2024	Reiterated by	Wedbush	Analyst D. Nierengarten	Outperform	$12.00	Low	View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 1/8/2024
BEAM Beam Therapeutics	$28.11 +2.0%	1/8/2024	Reiterated by	Wedbush	-	Outperform	$48.00	Low	View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 1/8/2024
NVCR NovoCure	$14.85 -0.7%	1/8/2024	Reiterated by	Wedbush	-	Neutral	$21.00	Low	View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 1/8/2024
ITOS iTeos Therapeutics	$10.64 +6.3%	1/8/2024	Reiterated by	Wedbush	-	Outperform	$33.00	Low	View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 1/8/2024
ORIC ORIC Pharmaceuticals	$12.25 -2.9%	1/8/2024	Reiterated by	Wedbush	-	Outperform	$12.00	Low	View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 1/8/2024
NUVL Nuvalent	$80.58 +2.3%	1/8/2024	Reiterated by	Wedbush	-	Outperform	$74.00 -> $82.00	Low	View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 1/8/2024
ASND Ascendis Pharma A/S	$139.25 0.0%	1/8/2024	Reiterated by	Wedbush	-	Outperform	$202.00 -> $207.00	Low	View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 1/8/2024
DOOR Masonite International	$96.59 +1.4%	1/8/2024	Reiterated by	Wedbush	-	Neutral	$92.00	Low	View details for Wedbush rating of Masonite International (NYSE:DOOR) on 1/8/2024
SWTX SpringWorks Therapeutics	$46.43 +3.8%	1/8/2024	Reiterated by	Wedbush	-	Outperform	$45.00	Low	View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 1/8/2024
BANC Banc of California	$12.96 +1.7%	1/3/2024	Reiterated by	Wedbush	Analyst D. Chiaverini	Neutral		Low	View details for Wedbush rating of Banc of California (NYSE:BANC) on 1/3/2024

PCRX Pacira BioSciences	$27.70 -2.8%	1/5/2024	Reiterated by	Wedbush	-	Outperform	$57.00	Low	View details for Wedbush rating of Pacira BioSciences (NASDAQ:PCRX) on 1/5/2024
SIMO Silicon Motion Technology	$67.90 +1.4%	1/5/2024	Reiterated by	Wedbush	-	Outperform	$85.00	Low	View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 1/5/2024
STRO Sutro Biopharma	$4.77 +1.5%	1/5/2024	Reiterated by	Wedbush	-	Outperform	$12.00	Low	View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 1/5/2024
KBH KB Home	$60.66 +1.2%	1/5/2024	Reiterated by	Wedbush	Analyst J. Mccanless	Neutral	$55.00	Low	View details for Wedbush rating of KB Home (NYSE:KBH) on 1/5/2024
GOEV Canoo	$0.16	1/5/2024	Initiated by	Wedbush	Analyst D. Ives	Outperform	$4.00	Low	View details for Wedbush rating of Canoo (NYSE:GOEV) on 1/5/2024
NYCB New York Community Bancorp	$4.19 -6.7%	1/4/2024	Downgraded by	Wedbush	Analyst D. Chiaverini	Neutral -> Underperform		Low	View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 1/4/2024
ACET Adicet Bio	$3.38 +5.3%	1/4/2024	Reiterated by	Wedbush	-	Outperform	$5.00	Low	View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 1/4/2024
TCRX TScan Therapeutics	$6.00 +3.4%	1/4/2024	Reiterated by	Wedbush	-	Outperform	$9.00	Low	View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 1/4/2024
SRRK Scholar Rock	$15.71 -1.9%	1/4/2024	Reiterated by	Wedbush	-	Outperform	$23.00	Low	View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 1/4/2024
OMGA Omega Therapeutics	$3.60 +0.3%	1/4/2024	Reiterated by	Wedbush	-	Outperform -> Outperform	$12.00	Low	View details for Wedbush rating of Omega Therapeutics (NASDAQ:OMGA) on 1/4/2024
RVMD Revolution Medicines	$30.38 +1.2%	1/4/2024	Initiated by	Wedbush	Analyst R. Driscoll	Outperform	$41.00	Low	View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 1/4/2024
KROS Keros Therapeutics	$51.30 -0.2%	1/3/2024	Reiterated by	Wedbush	Analyst A. Argyrides	Outperform	$86.00	Low	View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 1/3/2024
NYCB New York Community Bancorp	$4.19 -6.7%	1/3/2024	Upgraded by	Wedbush	Analyst D. Chiaverini	Underperform -> Neutral	$8.00	Low	View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 1/3/2024
KNSA Kiniksa Pharmaceuticals	$19.02 +5.0%	1/2/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$23.00 -> $25.00	Low	View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 1/2/2024
PFSI PennyMac Financial Services	$90.32 +1.1%	1/2/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$85.00 -> $105.00	Low	View details for Wedbush rating of PennyMac Financial Services (NYSE:PFSI) on 1/2/2024
WD Walker & Dunlop	$94.97 +2.9%	1/2/2024	Target Raised by	Wedbush	-	Outperform -> Outperform	$110.00 -> $130.00	Low	View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 1/2/2024
GTHX G1 Therapeutics	$4.70 -2.7%	1/2/2024	Reiterated by	Wedbush	-	Outperform	$5.00	Low	View details for Wedbush rating of G1 Therapeutics (NASDAQ:GTHX) on 1/2/2024
FUSN Fusion Pharmaceuticals	$11.32 -4.3%	1/2/2024	Reiterated by	Wedbush	-	Outperform	$13.00	Low	View details for Wedbush rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 1/2/2024
IRON Disc Medicine	$66.73 +2.3%	1/2/2024	Reiterated by	Wedbush	-	Outperform	$79.00	Low	View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 1/2/2024
TYRA Tyra Biosciences	$18.26 +1.4%	12/29/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$27.00	Low	View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 12/29/2023
MSFT Microsoft	$414.11 +0.0%	12/28/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$425.00 -> $450.00	Low	View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 12/28/2023
ALIT Alight	$9.23 +2.6%	12/28/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$11.00 -> $13.00	Low	View details for Wedbush rating of Alight (NYSE:ALIT) on 12/28/2023
EXPE Expedia Group	$159.47 +3.3%	12/27/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$115.00 -> $130.00	Low	View details for Wedbush rating of Expedia Group (NASDAQ:EXPE) on 12/27/2023
CART Maplebear	$26.07 +6.6%	12/27/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$30.00 -> $26.00	Low	View details for Wedbush rating of Maplebear (NASDAQ:CART) on 12/27/2023
LYFT Lyft	$12.78 +2.7%	12/27/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$12.00 -> $14.00	Low	View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 12/27/2023
MELI MercadoLibre	$1,732.83 +1.1%	12/27/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$1,700.00 -> $1,800.00	Low	View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 12/27/2023
META Meta Platforms	$470.00 +0.1%	12/27/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$350.00 -> $420.00	Low	View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 12/27/2023
PINS Pinterest	$40.71 -0.3%	12/27/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$32.00 -> $35.00	Low	View details for Wedbush rating of Pinterest (NYSE:PINS) on 12/27/2023
BKNG Booking	$3,840.22 +3.5%	12/27/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$3,300.00 -> $3,850.00	Low	View details for Wedbush rating of Booking (NASDAQ:BKNG) on 12/27/2023
CTSH Cognizant Technology Solutions	$78.30 +0.4%	12/26/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$75.00 -> $85.00	Low	View details for Wedbush rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 12/26/2023
KRTX Karuna Therapeutics	$316.12 +0.7%	12/22/2023	Downgraded by	Wedbush	Analyst L. Chico	Outperform -> Neutral	$330.00	Low	View details for Wedbush rating of Karuna Therapeutics (NASDAQ:KRTX) on 12/22/2023
TSLA Tesla	$189.56 +1.1%	12/22/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$310.00 -> $350.00	Low	View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 12/22/2023
BROS Dutch Bros	$26.39 +2.5%	12/21/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$35.00 -> $37.00	Low	View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 12/21/2023
LQDA Liquidia	$14.68 +0.7%	12/21/2023	Reiterated by	Wedbush	-	Underperform -> Underperform	$3.00	Low	View details for Wedbush rating of Liquidia (NASDAQ:LQDA) on 12/21/2023
MU Micron Technology	$84.88 -0.3%	12/21/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$95.00	Low	View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 12/21/2023
NFLX Netflix	$558.53 -0.1%	12/21/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$525.00	Low	View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 12/21/2023
AMZN Amazon.com	$169.84 -0.4%	12/21/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$180.00 -> $210.00	Low	View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 12/21/2023
WEN Wendy's	$19.08 +0.8%	12/21/2023	Downgraded by	Wedbush	Analyst N. Setyan	Outperform -> Neutral	$21.00	Low	View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 12/21/2023
CMG Chipotle Mexican Grill	$2,620.48 -1.7%	12/21/2023	Downgraded by	Wedbush	Analyst N. Setyan	Outperform -> Neutral	$2,400.00	Low	View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 12/21/2023
CAKE Cheesecake Factory	$35.64 +4.2%	12/21/2023	Upgraded by	Wedbush	Analyst N. Setyan	Neutral -> Outperform	$34.00 -> $40.00	Low	View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 12/21/2023
CAVA CAVA Group	$52.75 +2.7%	12/21/2023	Upgraded by	Wedbush	Analyst N. Setyan	Neutral -> Outperform	$35.00 -> $48.00	Low	View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 12/21/2023
KMX CarMax	$73.30 +1.4%	12/20/2023	Target Raised by	Wedbush	Analyst S. Basham	Overweight -> Overweight	$80.00 -> $90.00	Low	View details for Wedbush rating of CarMax (NYSE:KMX) on 12/20/2023
ASND Ascendis Pharma A/S	$139.25 0.0%	12/20/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$200.00 -> $202.00	Low	View details for Wedbush rating of Ascendis Pharma A/S (NASDAQ:ASND) on 12/20/2023
AAPL Apple	$188.32 -0.6%	12/20/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$250.00	Low	View details for Wedbush rating of Apple (NASDAQ:AAPL) on 12/20/2023
GOSS Gossamer Bio	$0.86 -1.1%	12/19/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$6.00	Low	View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 12/19/2023
IMNM Immunome	$23.49 -5.7%	12/19/2023	Initiated by	Wedbush	Analyst D. Nierengarten	Outperform	$12.00	Low	View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 12/19/2023
DRI Darden Restaurants	$168.18 +1.3%	12/18/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$165.00 -> $177.00	Low	View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 12/18/2023
TPH Tri Pointe Homes	$35.16 +1.2%	12/18/2023	Reiterated by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$32.00	Low	View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 12/18/2023
TMHC Taylor Morrison Home	$53.61 +1.5%	12/18/2023	Reiterated by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$52.00	Low	View details for Wedbush rating of Taylor Morrison Home (NYSE:TMHC) on 12/18/2023
SKY Skyline Champion	$79.51 +2.6%	12/18/2023	Reiterated by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$72.00	Low	View details for Wedbush rating of Skyline Champion (NYSE:SKY) on 12/18/2023

MTH Meritage Homes	$154.54 +0.7%	12/18/2023	Downgraded by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$170.00	Low	View details for Wedbush rating of Meritage Homes (NYSE:MTH) on 12/18/2023
DOOR Masonite International	$96.59 +1.4%	12/18/2023	Downgraded by	Wedbush	-	Outperform -> Neutral	$92.00	Low	View details for Wedbush rating of Masonite International (NYSE:DOOR) on 12/18/2023
MHO M/I Homes	$122.36 +1.8%	12/18/2023	Downgraded by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$116.00	Low	View details for Wedbush rating of M/I Homes (NYSE:MHO) on 12/18/2023
CCS Century Communities	$87.44 +1.9%	12/18/2023	Downgraded by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$81.00	Low	View details for Wedbush rating of Century Communities (NYSE:CCS) on 12/18/2023
EXLS ExlService	$30.64 -0.2%	12/14/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$34.00	Low	View details for Wedbush rating of ExlService (NASDAQ:EXLS) on 12/14/2023
ACN Accenture	$368.53 +0.5%	12/14/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$330.00 -> $360.00	Low	View details for Wedbush rating of Accenture (NYSE:ACN) on 12/14/2023
PANW Palo Alto Networks	$367.02 +0.7%	12/14/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$290.00 -> $350.00	Low	View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 12/14/2023
ETSY Etsy	$74.49 +1.7%	12/14/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$60.00 -> $90.00	Low	View details for Wedbush rating of Etsy (NASDAQ:ETSY) on 12/14/2023
VICI VICI Properties	$29.67 -0.1%	12/14/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$30.00	Low	View details for Wedbush rating of VICI Properties (NYSE:VICI) on 12/14/2023
TPX Tempur Sealy International	$51.85 +1.2%	12/13/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$50.00	Low	View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 12/13/2023
SLM SLM	$19.50 +2.1%	12/13/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$18.00 -> $21.00	Low	View details for Wedbush rating of SLM (NASDAQ:SLM) on 12/13/2023
COGT Cogent Biosciences	$6.38 +7.2%	12/11/2023	Downgraded by	Wedbush	Analyst D. Nierengarten	Outperform -> Neutral	$20.00 -> $5.00	Low	View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 12/11/2023
AAPL Apple	$188.32 -0.6%	12/11/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$240.00 -> $250.00	Low	View details for Wedbush rating of Apple (NASDAQ:AAPL) on 12/11/2023
TXRH Texas Roadhouse	$135.49 +2.2%	12/11/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$120.00	Low	View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 12/11/2023
WD Walker & Dunlop	$94.97 +2.9%	12/11/2023	Target Raised by	Wedbush	-	Outperform	$90.00 -> $110.00	Low	View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 12/11/2023
LULU Lululemon Athletica	$472.98 +3.3%	12/8/2023	Target Raised by	Wedbush	-	Outperform	$420.00 -> $503.00	Low	View details for Wedbush rating of Lululemon Athletica (NASDAQ:LULU) on 12/8/2023
SHOP Shopify	$87.88 +3.2%	12/6/2023	Reiterated by	Wedbush	Analyst S. Devitt	Outperform -> Neutral	$66.00 -> $68.00	Low	View details for Wedbush rating of Shopify (NYSE:SHOP) on 12/6/2023
VRDN Viridian Therapeutics	$17.96 +1.2%	12/4/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$37.00	Low	View details for Wedbush rating of Viridian Therapeutics (NASDAQ:VRDN) on 12/4/2023
MLTX MoonLake Immunotherapeutics	$61.25 +2.2%	12/1/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$92.00	Low	View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 12/1/2023
ARDX Ardelyx	$9.27 +3.3%	12/1/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$9.00	Low	View details for Wedbush rating of Ardelyx (NASDAQ:ARDX) on 12/1/2023
CROX Crocs	$104.31 +4.3%	12/1/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$96.00 -> $120.00	Low	View details for Wedbush rating of Crocs (NASDAQ:CROX) on 12/1/2023
DECK Deckers Outdoor	$832.41 -0.1%	12/1/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$650.00 -> $705.00	Low	View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 12/1/2023
CVNA Carvana	$52.39 +8.9%	12/1/2023	Reiterated by	Wedbush	Analyst S. Basham	Neutral -> Neutral	$40.00	Low	View details for Wedbush rating of Carvana (NYSE:CVNA) on 12/1/2023
ASO Academy Sports and Outdoors	$66.34 +3.2%	12/1/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$60.00	Low	View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 12/1/2023
AMZN Amazon.com	$169.84 -0.4%	12/1/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$180.00	Low	View details for Wedbush rating of Amazon.com (NASDAQ:AMZN) on 12/1/2023
ESTC Elastic	$126.58 +0.9%	12/1/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$67.00	Low	View details for Wedbush rating of Elastic (NYSE:ESTC) on 12/1/2023
TXRH Texas Roadhouse	$135.49 +2.2%	12/1/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$110.00 -> $120.00	Low	View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 12/1/2023
GME GameStop	$14.35 +2.0%	11/30/2023	Reiterated by	Wedbush	-	Underperform -> Underperform	$6.00	Low	View details for Wedbush rating of GameStop (NYSE:GME) on 11/30/2023
ABR Arbor Realty Trust	$12.12 -1.1%	11/30/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$17.00	Low	View details for Wedbush rating of Arbor Realty Trust (NYSE:ABR) on 11/30/2023
PVH PVH	$127.06 +6.1%	11/30/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$88.00	Low	View details for Wedbush rating of PVH (NYSE:PVH) on 11/30/2023
WOOF Petco Health and Wellness	$2.55 +1.2%	11/30/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$4.50 -> $3.50	Low	View details for Wedbush rating of Petco Health and Wellness (NASDAQ:WOOF) on 11/30/2023
PSTG Pure Storage	$44.15 +3.8%	11/30/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$45.00 -> $40.00	Low	View details for Wedbush rating of Pure Storage (NYSE:PSTG) on 11/30/2023
GM General Motors	$38.65 -0.2%	11/30/2023	Target Lowered by	Wedbush	-	Outperform -> Outperform	$46.00 -> $40.00	Low	View details for Wedbush rating of General Motors (NYSE:GM) on 11/30/2023
CRM Salesforce	$291.98 +1.1%	11/30/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$255.00 -> $280.00	Low	View details for Wedbush rating of Salesforce (NYSE:CRM) on 11/30/2023
OKTA Okta	$84.68 +1.3%	11/30/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$90.00	Low	View details for Wedbush rating of Okta (NASDAQ:OKTA) on 11/30/2023
ANAB AnaptysBio	$23.13 -1.6%	11/29/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$20.00	Low	View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 11/29/2023
TOL Toll Brothers	$100.24 +0.5%	11/29/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$82.00	Low	View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 11/29/2023
SHOO Steven Madden	$40.96 +1.8%	11/29/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$36.00	Low	View details for Wedbush rating of Steven Madden (NASDAQ:SHOO) on 11/29/2023
BLDR Builders FirstSource	$185.33 +2.4%	11/29/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$175.00	Low	View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 11/29/2023
SKX Skechers U.S.A.	$57.98 +1.6%	11/29/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$59.00 -> $62.00	Low	View details for Wedbush rating of Skechers U.S.A. (NYSE:SKX) on 11/29/2023
AZO AutoZone	$2,731.66 -3.9%	11/29/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$2,750.00	Low	View details for Wedbush rating of AutoZone (NYSE:AZO) on 11/29/2023
NTAP NetApp	$88.92 +1.9%	11/29/2023	Target Raised by	Wedbush	-	Neutral -> Neutral	$75.00 -> $85.00	Low	View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 11/29/2023
CRNC Cerence	$15.80 -1.0%	11/28/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$31.00 -> $19.00	N/A	View details for Wedbush rating of Cerence (NASDAQ:CRNC) on 11/28/2023
TSLA Tesla	$189.56 +1.1%	11/28/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$310.00	Low	View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 11/28/2023
ZS Zscaler	$249.41 +1.9%	11/28/2023	Target Raised by	Wedbush	-	Outperform -> Outperform	$185.00 -> $210.00	Low	View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 11/28/2023
CRWD CrowdStrike	$323.04 +1.7%	11/28/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$200.00	Low	View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 11/28/2023
AAPL Apple	$188.32 -0.6%	11/24/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$240.00	Low	View details for Wedbush rating of Apple (NASDAQ:AAPL) on 11/24/2023
ASO Academy Sports and Outdoors	$66.34 +3.2%	11/22/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$60.00	Low	View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 11/22/2023
LOW Lowe's Companies	$220.30 -0.6%	11/22/2023	Target Lowered by	Wedbush	-	Neutral -> Neutral	$230.00 -> $215.00	Low	View details for Wedbush rating of Lowe’s Companies (NYSE:LOW) on 11/22/2023
DKS DICK'S Sporting Goods	$159.97 +0.9%	11/22/2023	Target Raised by	Wedbush	Analyst S. Basham	Neutral -> Neutral	$115.00 -> $130.00	Low	View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 11/22/2023
BBY Best Buy	$75.49 +0.0%	11/22/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$70.00	Low	View details for Wedbush rating of Best Buy (NYSE:BBY) on 11/22/2023
MSFT Microsoft	$414.11 +0.0%	11/22/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$425.00	Low	View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 11/22/2023
DNTH Dianthus Therapeutics	$23.20 -4.1%	11/22/2023	Initiated by	Wedbush	Analyst L. Chico	Outperform	$23.00	Low	View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 11/22/2023
SRPT Sarepta Therapeutics	$127.38 +1.1%	11/21/2023	Initiated by	Wedbush	-	Outperform	$224.00	Low	View details for Wedbush rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/21/2023
CAKE Cheesecake Factory	$35.64 +4.2%	11/20/2023	Reiterated by	Wedbush	-	Neutral -> Neutral	$32.00	Low	View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 11/20/2023
TSVT 2seventy bio	$5.99 +7.2%	11/20/2023	Downgraded by	Wedbush	Analyst D. Nierengarten	Outperform -> Neutral		Low	View details for Wedbush rating of 2seventy bio (NASDAQ:TSVT) on 11/20/2023
KBH KB Home	$60.66 +1.2%	11/20/2023	Downgraded by	Wedbush	Analyst J. Mccanless	Outperform -> Neutral	$55.00	Low	View details for Wedbush rating of KB Home (NYSE:KBH) on 11/20/2023
KRTX Karuna Therapeutics	$316.12 +0.7%	11/17/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$253.00	Low	View details for Wedbush rating of Karuna Therapeutics (NASDAQ:KRTX) on 11/17/2023
OCS Oculis	$12.59 -0.5%	11/17/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$29.00	Low	View details for Wedbush rating of Oculis (NASDAQ:OCS) on 11/17/2023
GLOB Globant	$237.83 +0.7%	11/17/2023	Reiterated by	Wedbush	-	Outperform -> Outperform	$250.00	Low	View details for Wedbush rating of Globant (NYSE:GLOB) on 11/17/2023

MarketBeat Community Rating for Wedbush

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		22,972 (Vote Outperform)
Underperform Votes:		19,666 (Vote Underperform)
Total Votes:		42,638

MarketBeat's community ratings are surveys of what our community members think about Wedbush and other research firms. Vote "Outperform" if you believe Wedbush's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Wedbush's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Wedbush Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Wedbush

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info